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The development of effective therapies to pre-
vent and treat persistent infections is of the 
highest priority, as they cause considerable clini-
cal challenges and ongoing health care costs. 
Efforts to improve the treatment and preven-
tion of chronic viral infections, such as those 
elicited by HIV, hepatitis C virus (HCV), and 
human cytomegalovirus (HCMV), require a 
better understanding of the immune responses 
needed to achieve optimal control of persistent 
viruses in the long term. Although innate and 
adaptive  immune  responses  have  historically 
been thought to be nonoverlapping, recent ev-
idence clearly indicates that interplays between 
components of the immune system occur fre-
quently and form the basis of effective immu-
nity. Infection with murine cytomegalovirus 
(MCMV) is a well-established experimental 
system to study host–pathogen interactions and 
to dissect the relevance of different arms of the 
immune response. Because of the similarities 
in structure and biology between HCMV and 
MCMV, and because MCMV is a natural mouse 
pathogen, MCMV infection provides a unique 
model to study a medically important virus in 
vivo after infection of its biological host. Like 
HCMV,  MCMV  causes  persistent  infection, 
and thus the model can be exploited to gain a 
better understanding of the requirements for 
effective prevention and treatment of chronic 
viral infections.
Early control of MCMV infection is de-
pendent on NK cell responses and is associated 
with a single dominant locus that encodes the 
NK cell–activating receptor Ly49H (Brown 
et al., 2001; Daniels et al., 2001; Lee et al., 
2001). In mouse strains like C57BL/6J, NK cells 
express Ly49H and efficiently limit early viral 
replication (Bancroft et al., 1981; Shellam et al., 
1981; Bukowski et al., 1984; Scalzo et al., 
1990). Ly49H binds to the MCMV-encoded 
MHC class I like glycoprotein m157 to deliver 
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Effective immunity requires the coordinated activation of innate and adaptive immune 
responses. Natural killer (NK) cells are central innate immune effectors, but can also affect 
the generation of acquired immune responses to viruses and malignancies. How NK cells 
influence the efficacy of adaptive immunity, however, is poorly understood. Here, we show 
that NK cells negatively regulate the duration and effectiveness of virus-specific CD4+ and 
CD8+ T cell responses by limiting exposure of T cells to infected antigen-presenting cells. 
This impacts the quality of T cell responses and the ability to limit viral persistence. Our 
studies provide unexpected insights into novel interplays between innate and adaptive 
immune effectors, and define the critical requirements for efficient control of viral 
persistence.
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(NK1.1+, Ly49H+) mice, BALB.B6-CT8, and BALB.B6-
Cmv1r mice express the NK1.1 and Ly49H receptors. Mice 
from these three strains are herein collectively referred to as 
Ly49H+ mice and, because of the presence of the activating 
Ly49H receptor, they exhibit improved control of MCMV 
replication in the spleen during the early stage of acute infec-
tion (Scalzo et al., 1999). Importantly, the congenic strains 
allowed us to test how NK cell activation mediated by Ly49H 
affects subsequent antiviral responses on a common genetic 
background. The BALB/c background of these strains also 
enabled us to investigate virus-specific CD8+ T cell responses 
using the well characterized H-2Ld–restricted IE1 epitope. In 
addition to the prototype Ly49H– strain BALB/c, in our com-
parative studies we also used a BALB/c congenic strain carrying 
NK1.1, but lacking Ly49H, known as BALB.B6-CT6 (NK1.1+, 
Ly49H–; Scalzo et al., 1999). BALB/c and BALB.B6-CT6 
strains are herein collectively referred to as Ly49H– mice.
Antiviral cytotoxic T lymphocyte (CTL) responses were 
measured at 2, 4, 6, 8, and 10 d after infection. The in vivo 
CTL assay used in our studies measures the specific loss of 
IE1 peptide-pulsed targets in comparison to targets that have 
not been pulsed with peptide. Anti-IE1–specific CTL activity 
could not be detected in either Ly49H– (BALB/c) or Ly49H+ 
(BALB.B6-Cmv1r) mice at 2 d post-infection (pi), and was 
minimal at day 4 pi (Fig. 1 A). In both Ly49H– and Ly49H+ 
mice, maximal and equivalent CTL activity was observed at 
day 6 after MCMV infection (Fig. 1 A). However, in Ly49H+ 
mice, the CTL response was significantly reduced compared 
with Ly49H– mice at both day 8 (P < 0.005) and day 10 (P < 
0.0001) pi (Fig. 1 A). To determine whether the reduction in 
IE1-specific CTL killing was influenced by NK cell–mediated 
activities, Ly49H+ mice were depleted of NK cells. Maximal 
CTL  activity  was  observed  at  day  6  pi  in  both  untreated 
Ly49H– mice and Ly49H+ mice depleted of NK cells (Fig. 
1 B). At 10 d pi, Ly49H+ mice depleted of NK cells showed 
antiviral CTL activity equivalent to that observed in Ly49H– 
mice (Fig. 1 B). In contrast, and as expected, the CTL activity 
was reduced at 10 d pi in control Ig-treated Ly49H+ mice 
(Fig. 1 B). In Ly49H+ mice, NK cells are activated by engage-
ment of the Ly49H receptor by the viral protein m157. The 
reduced CTL activity observed in Ly49H+ mice was increased 
to Ly49H–-like levels by infection with an MCMV virus lack-
ing a functional m157 gene product, and thus unable to activate 
Ly49H+ NK cells (Fig. 1 C). Significant differences in anti-
viral CTL activity between Ly49H– (BALB/c) and Ly49H+ 
(BALB.B6-CT8) mice were detected out to day 40 pi (Fig. 
1 D). Despite early similarities in the kinetics of CTL response, 
these data provide evidence that there are ongoing differences 
in CTL function in Ly49H– versus Ly49H+ mice which are 
NK cell mediated and Ly49H dependent.
Having found that NK cells regulate the ongoing efficacy 
of cytolytic antiviral CD8+ T cell responses, the activation of 
MCMV-specific CD8+ T cells, as defined by IE1-tetramer 
binding, was compared by flow cytometry in infected Ly49H+ 
and Ly49H mice. A higher proportion of IE1+CD8+ T cells 
were positive for the early activation marker CD69 in Ly49H– 
activating signals to NK cells (Arase et al., 2002; Smith et al., 
2002). In contrast to C57BL/6J (Ly49H+) mice, BALB/c mice, 
whose NK cells lack the Ly49H-activating receptor, show 
increased susceptibility to MCMV during the early phase of 
infection (Allan and Shellam, 1984). In BALB/c (Ly49H–) mice, 
activation of NK cells is limited further by viral interference 
with the expression of ligands for the NKG2D NK cell–
activating receptor (Lodoen et al., 2003; Lodoen et al., 2004; 
Hasan et al., 2005; Krmpotic et al., 2005), and early control 
of MCMV infection requires a CD8 T cell–mediated response. 
The antiviral CD8+ T cell response commences within 4 d 
after infection and is directed predominantly against the non-
americ peptide YPHFMPTNL (Del Val et al., 1991), which is 
derived from the virus immediate early 1 (IE1) nonstructural 
protein (Volkmer et al., 1987). The IE1 epitope, specifically 
recognized by BALB/c CD8+ T cells in an H-2Ld–restricted 
manner, represents the best-studied MCMV antigenic deter-
minant. Despite the large body of evidence demonstrating a 
role for CD8+ T cells in limiting CMV, virus-specific CD4+ 
T cells are also important. Evidence from both HCMV and 
MCMV studies suggests that CD4+ T cell responses are a criti-
cal component of immunity to these viruses. In humans, virus-
specific CD4+ T cells are required to control HCMV-induced 
disease (Hsieh et al., 2001; Gamadia et al., 2003). In MCMV 
infection, CD4+ T cells participate in limiting viral replica-
tion in salivary glands (Jonjic et al., 1989).
Our recent study demonstrated that interplays between 
DCs and NK cells during the very early phase of infection are 
important to achieve maximal control of the virus (Andoniou 
et al., 2005). Functional interrelationships between DCs and 
Ly49H+ NK cells occur during the late stage of acute MCMV 
infection in vivo (Andrews et al., 2003). Although Ly49H+ 
NK cells are undoubtedly important for the early control of 
viral infection in visceral organs (Brown et al., 2001; Daniels 
et al., 2001; Lee et al., 2001), it has been postulated that they 
may also regulate ensuing adaptive antiviral immune re-
sponses (Dokun et al., 2001; Su et al., 2001; Andrews et al., 
2003). Recent studies have shown that NK cells promote 
early activation of MCMV-specific CD8+ T cells through 
the ability to regulate the production of IFN- (Robbins 
et al., 2007). These effects however are transient, and it is 
unclear whether they impact on controlling virus replication. 
Here, we exploited the differences in NK cell activation 
that occur in Ly49H– (e.g., BALB/c) versus Ly49H+ (e.g., 
C57BL/6) mice during MCMV infection to investigate the 
impact of differences in NK cell responses on the generation, 
maintenance, and in vivo effectiveness of antiviral CD4+ and 
CD8+ T cell responses.
RESULTS
NK cells affect antigen-specific CD8 T cell responses
To assess the interplay between NK cell–mediated activity 
and antiviral T cell responses we used BALB/c congenic 
mice (BALB.B6-CT8 or BALB.B6-Cmv1r), whose Natural 
Killer Complex (NKC) encodes the NK1.1 (NKR-P1C) and 
Ly49H NK cell receptors (Scalzo et al., 1999). Like C57BL/6J JEM VOL. 207, June 7, 2010 
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(BALB.B6-CT6) mice compared with Ly49H+ (BALB.B6-
CT8) mice on both 6 and 10 d pi (Fig. 2 A). In contrast, early 
CD8+ T cell activation was equivalent in both strains, with 
80–90% of CD8+ T cells positive for CD69 at 2 d pi (CT6, 
93.6 ± 1.56%; CT8, 83.95 ± 3.7%). The frequency of CD8 
T cells producing both IFN- and TNF-, an indicator of 
functional competence, was also examined and found to be 
higher in Ly49H– mice compared with Ly49H+ mice at both 
day 6 and 10 pi (Fig. 2 B). Therefore, the activation and ef-
fector function of virus-specific CD8+ T cells, as assessed by 
measuring cytotoxicity and cytokine production, is greater in 
Ly49H– mice compared with Ly49H+ mice.
NK cells affect antiviral CD4 T cell responses
Next, we examined whether virus-specific CD4+ T cell 
responses were similarly affected by NK cells. Given that 
CD4-restricted MCMV epitopes have not been defined for 
BALB/c mice, we measured the frequency of CD4+ T cells 
able to produce IFN- after culture of lymphocytes with 
MCMV-infected DC as a source of antigen. At day 10 pi, 
the proportion of CD4+ T cells secreting IFN-+ was sig-
nificantly higher (P = 0.0022) in Ly49H– (BALB/c) mice 
compared with Ly49H+ (BALB.B6-CT8) mice (Fig. 3 A). 
Depletion of NK cells in Ly49H+ mice increased the fre-
quency of CD4+ IFN-+ T cells to a level comparable to that 
observed in Ly49H– mice, and significantly different to that 
observed in undepleted Ly49H+ mice (P = 0.045 at day 10 pi; 
Fig. 3 A). The increased proportions of CD4+ IFN-+ T cells 
translated into increased numbers in Ly49H– mice compared 
with Ly49H+ mice (P = 0.026). Similarly, NK depletion in-
creased the numbers of CD4+ IFN-+ T cells in Ly49H+ mice 
to levels similar to those observed in Ly49H– mice (Fig. 3 B).
NK cells determine the extent of DC/APC infection
Having shown that in Ly49H+ mice NK cells impair antiviral 
CD4 and CD8 T cell responses, we sought to define the rel-
evant underlying mechanisms. DCs play the most critical role 
in the generation of adaptive T cell responses (Steinman and 
Witmer, 1978; Jung et al., 2002). Viral infection of DCs al-
lows for the generation of epitopes that can be presented to 
CD4+ and CD8+ T cells. Early antiviral immune responses, 
Figure 1.  NK cells affect antiviral CTL function. Ly49H and 
Ly49H+ mice were infected with MCMV (5 × 103 PFU K181-Perth). (A) Virus-
specific CTL activity was assessed in vivo at days 2, 4, 6, 8, and 10 pi by mea-
suring the elimination of adoptively transferred CFSE low targets pulsed 
with the IE1 viral peptide. Unpulsed (CFSE high) targets are used for com-
parison. The histograms represent the number of CFSE high (unpulsed) 
and CFSE low (IE1 pulsed) targets in the spleens of relevant mice. The data 
are representative of at least two experiments each using three mice per 
time point. (bottom) CTL data are shown as percentage of IE1-specific 
cytotoxicity determined as described in the Materials and methods sec-
tion. Arithmetic means and standard errors were plotted using the results 
from two independent experiments each using three mice per time-point. 
(B) Ly49H, Ly49H+ isotype-matched control Ig-treated mice, and Ly49H+ 
anti-NK1.1–treated mice were infected with MCMV (5 × 103 PFU). Virus-
specific CTL activity was measured in vivo at days 6 and 10 pi. Data 
are representative of at least five independent experiments each using 
three mice per time point. (right) CTL data are shown as percentage of 
IE1-specific cytotoxicity. Arithmetic means and standard errors were plot-
ted using the results from two independent experiments each using three 
mice per time point. (C) Ly49H+ mice were infected with wild-type MCMV 
(MCMV-m157wt) or a mutant MCMV virus with a nonfunctional m157 
glycoprotein (MCMV-m157mut). CTL data are plotted as percentage of 
IE1-specific cytotoxicity. CTL data from Ly49H mice infected with wild-type 
MCMV are shown for comparison. Arithmetic means and standard errors 
are plotted. The data are representative of at least three independent 
experiments each with at least three mice per group (D) Virus-specific CTL 
activity was measured at days 18, 25, 32, and 40 after infection in  
(Ly49H) and  (Ly49H+) mice. Data are representative of two indepen-
dent experiments each using 3 mice per group. Arithmetic means and 
standard errors are plotted. The differences were significant at all times. 
P < 0.0005. Experiments described in A–C were performed in BALB/c 
(Ly49H) and BALB.B6-Cmv1r (Ly49H+) mice. Experiments described in D 
were performed in BALB/c (Ly49H) and BALB.B6-CT8 (Ly49H+) mice.
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cells (Fig. 4, A and C). Thus, elimination of infected DCs/
APCs is NK cell–mediated and perforin dependent. Un-
like Ly49H+ BALB.B6-Cmv1r.pfp/ mice, Ly49H+ BALB.
B6-Cmv1r mice depleted of NK cells did not show a further 
increase in infected DCs at day 6 pi (Fig. 4), suggesting that 
perforin-dependent CTL activity may be involved in elimi-
nating infected DCs from day 6 onwards.
One explanation for the longevity of the CTL response in 
Ly49H– mice is an increased viral load. Thus, we challenged 
Ly49H– mice with a viral dose (102 PFU) that results in viral 
titers below the limit of detection (Andrews et al., 2008). On 
day 10 pi, this dose of virus produced a CTL response (89.0 ± 
1.2%) as robust as that induced by infection with 5 × 103 PFU 
of virus (86.0 ± 1.3%). Thus, the differences in CTL activity 
observed in Ly49H– versus Ly49H+ mice were not caused by 
differences in viral loads (Table S1).
such as those mediated by NK cells, may affect the extent to 
which DCs are infected or may lead to their elimination soon 
after infection. Thus, NK cell–mediated responses may re-
duce the number of DCs able to present viral antigens, and 
consequently affect the generation and/or maintenance of 
virus-specific CD4+ and CD8+ T cells. We have previously 
shown that MCMV targets DCs in vivo (Andrews et al., 
2001) and that there is a phenotypic difference in the DC 
compartment of MCMV-infected Ly49H– and Ly49H+ mice 
(Andrews et al., 2003). To define the extent and duration of 
DC infection in Ly49H– and Ly49H+ mice, we used a re-
combinant MCMV expressing LacZ, so that infected cells 
could be identified and enumerated. Infection of DCs was 
monitored at 2, 4, and 6 d pi using fluorescein di-galactosidase 
(FDG), as previously described (Andrews et al., 2001), in com-
bination with CD11c, CD11b, MHC-II, and CD8. A signif-
icantly higher frequency of infected CD11c+ DCs was observed 
in Ly49H– mice compared with Ly49H+ (BALB.B6-CT8) 
mice at all times pi (P = 0.0153 at day 2; P = 0.0006 at day 4; 
P = 0.0202 at day 6 pi; Fig. 4 A). To assess the role of NK 
cells in limiting DC/APC infection, Ly49H+ mice were 
depleted of NK cells before infection with MCMV-LacZ. 
Analysis of infected splenocytes (LacZ/FDG+) revealed a dif-
ference in the number of infected MHC-II+ APC/DC in 
Ly49H– versus Ly49H+ mice over the course of infection; 
this difference was not observed in Ly49H+ mice depleted of 
NK cells (Fig. 4 B). To determine the mechanism by which 
NK cells affect the frequency of infected APCs present over 
the course of infection, we examined the frequency of these 
cells in Ly49H+ mice lacking the cytolytic effector molecule 
perforin (pfp). In BALB.B6-Cmv1r.pfp/ mice, the frequency 
of CD11c+ LacZ+ cells was increased at all times pi compared 
with wild-type Ly49H+ BALB.B6-Cmv1r mice (Fig. 4 C). 
At day 4 after infection, the frequency of infected DCs in 
Ly49H+ perforin-deficient mice was equivalent to that ob-
served in Ly49H mice or in Ly49H+ mice depleted of NK 
Figure 2.  Differences in CD8+ T cells from Ly49H and Ly49H+ 
mice. Ly49H and Ly49H+ mice were infected with 5 × 103 PFU MCMV 
and splenocytes harvested at day 6 and 10 pi. (A) Expression of CD69 was 
assessed on live TCR+CD8+IE1-tetramer+ cells. The frequency of CD69+ 
CD8+IE1-tetramer+ cells is plotted. Frequencies are shown as arithmetic 
means with standard errors. The data are representative of two indepen-
dent experiments each with three mice per group. (B) The frequencies of 
IFN-+TNF-+ CD8+IE1+ cells are plotted. The data are representative of 
two independent experiments each with three mice per group. Frequen-
cies are shown as arithmetic means with standard errors. Experiments 
were performed in BALB/c (Ly49H) and BALB.B6-CT8 (Ly49H+) mice.
Figure 3.  NK cells affect the frequency of activated CD4+IFN-+ 
T cells. Ly49H, Ly49H+, and Ly49H+ NK1.1-depleted mice were infected 
with MCMV (5 × 103 PFU). (A) The frequencies of CD4+IFN-+ T cells in the 
liver at days 6 and 10 pi are shown. The frequencies of IFN-+ cells are 
shown as a percentage of TCR+CD4+ cells. Density plots are representative 
of results from three independent experiments using three mice per time 
point, except the NK depletion which was performed once. Frequencies of 
cells in each boxed region are shown as arithmetic means with standard 
errors. (B) The numbers of CD4+IFN-+ T cells in the liver at days 6 and 
10 pi are shown as arithmetic means with standard errors. The experiments 
were performed in BALB/c (Ly49H) and BALB.B6-CT8 (Ly49H+) mice.JEM VOL. 207, June 7, 2010 
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Because viral load could not explain the longevity of the 
CTL response in Ly49H– mice, we examined the amount of 
viral peptide–MHC complex available to T cells. To formally 
determine whether NK cells affect the amount of viral peptide–
MHC complex available to T cells, and hence are responsi-
ble for the differences in antiviral T cell responses, we used a 
functional assay that measures the proliferation of naive T cells 
in an antigen-specific manner. This assay specifically quantifies 
the amount of viral peptide antigen presented by DC/APC to 
T cells, rather than total amount of antigen/virus. In this assay, 
purified T cells from TCR-transgenic mice are cultured with 
DCs enriched from MCMV-infected mice and CFSE labeling 
is used to measure the extent of T cell proliferation, which is 
directly proportional to the amount of antigen presented by 
the infected APCs. Ly49H– (BALB.B6-CT6) and Ly49H+ 
(BALB.B6-CT8) mice were infected with a recombinant 
MCMV expressing the HA epitope of influenza (MCMV-
K181-HA), and APC populations enriched by density gradient 
and negative antibody enrichment on days 0, 2, 4, and 6 pi. 
The phenotype of the enriched APC populations was analyzed 
to determine the frequency of cDCs and pDCs (Fig. 5 A). En-
riched APC populations were subsequently co-cultured with 
CFSE-labeled HA-specific T cells isolated from the lymph 
nodes of HA-transgenic CL4 mice and the proliferation of 
CD8+ T cells measured. Naive antigen-specific CD8+ T cells 
proliferated equally well when incubated with APCs isolated 
from either Ly49H– or Ly49H+ mice at day 2 pi (Fig. 5 B, top). 
In contrast, proliferation was observed in naive antigen-specific 
T cells when these were primed by APCs isolated at 4 or 
6 d pi from infected Ly49H– mice, but not when they were 
primed by APC isolated from infected Ly49H+ mice (Fig. 5 B, 
middle and bottom). These data provide evidence that the mo-
lecular basis for the observed differences in antiviral T cell re-
sponses in the presence of effective NK cell responses is the 
difference in the frequency and number of infected APCs/DCs 
that can prime naive T cells and recruit them to the effector 
population. These results further validate our hypothesis that 
the impaired T cell responses observed in Ly49H+ mice are 
caused by the elimination of infected DCs and the consequent 
reduction in the amount of viral peptide–MHC complexes 
available to T cells.
The longevity of antiviral T cell responses determines the 
extent of viral persistence
Control of viral replication in visceral organs (spleen, liver, 
and lung) of Ly49H– mice is dependent on IE1-specific CTL  Figure 4.  Sustained APC infection in Ly49H mice, but not in 
Ly49H+ mice. (A) Ly49H (BALB/c) and Ly49H+ (BALB.B6-CT8) mice were 
infected with 5 × 103 PFU of MCMV-K181-LacZ, and the frequency of 
infected APCs in the spleen was measured 2, 4, and 6 d pi using FDG. 
Histograms represent the expression of FDG-LacZ in CD11c+ MHC-II+ cells 
from the spleen. The proportion of FDG+ cells was first corrected for back-
ground fluorescence by subtracting the FDG+ values measured in unin-
fected controls. Arithmetic means and standard errors are shown. 
Uninfected controls are shown as a solid black line. Infected mice are 
shown as gray-filled histograms. The frequencies of infected FDG+ cells 
are shown and represent data from three mice. The data are representa-
tive of two independent experiments. (B) The number of infected MHC-II+ 
APC in the spleens of MCMV infected mice at days 2, 4, and 6 d pi are 
shown. The numbers of infected MHC-II+ APC were determined using FDG 
after correction for background fluorescence. Arithmetic means and stan-
dard errors are shown. (C) Ly49H+ BALB.B6-Cmv1r and BALB.B6-Cmv1r.
pfp/ mice were infected with 5 × 103 PFU of MCMV-K181-LacZ. Histo-
grams represent the expression of FDG-LacZ in CD11c+ MHC-II+ cells puri-
fied from the spleen. Uninfected controls are shown as a solid black line. 
Infected mice (n = 3) are shown as gray filled histograms. The data are 
representative of 3 independent experiments.
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mice after infection with wild-type MCMV 
were significantly reduced after infection with 
m157 mutant viruses (P < 0.05 d 40 MCMV 
m157MUT versus MCMV m157REV; Fig. 6 C). 
Thus, activation of NK cells, through engage-
ment of Ly49H by the m157 viral protein, favors MCMV 
persistence in salivary glands. These data demonstrate that 
Ly49H-mediated NK cell activation regulates the responses 
required to limit viral persistence in salivary glands.
Although a role for CD4+ T cells in controlling virus rep-
lication in salivary gland has been reported (Jonjic et al., 1989; 
Lucin et al., 1992), virus-specific CD8+ T cells are detected 
in this organ in high numbers (Cavanaugh et al., 2003). Fur-
thermore, vaccination protocols that induce CD8+IFN-+  
T cells have been reported to effectively reduce viral persistence 
in the salivary gland (Rouvio et al., 2005). To determine the 
relative importance of CD4+ versus CD8+ T cells in limiting 
persistent MCMV infection, we compared the numbers of 
CD4+IFN-+ and CD8+IE1+ T cells in the salivary glands 
of  Ly49H–  (BALB/c  and  BALB.B6.CT6)  and  Ly49H+ 
(BALB.B6-CT8) mice. Significantly higher numbers of both 
CD8+IE1+ (Fig. 7 A) and CD4+IFN-+ T cells (Fig. 7 B) were 
detected in the salivary glands of infected Ly49H– mice at 
days 10, 18, and 25 pi. These data suggest that differences in 
virus-specific CD4+ and CD8+ T cells may contribute to the 
differences in the ability to limit persistent MCMV infection 
observed between Ly49H– and Ly49H+ mice.
To formally define the specific role of CD4+ and CD8+ 
T cells in limiting persistent viral infection, we performed 
timed depletion of these cell subsets from Ly49H– mice late 
in infection. Depletions were commenced 16 d before mea-
suring viral replication in salivary glands. Depletion of CD8+ 
T cells did not significantly affect viral titers at any of the time 
points tested (Fig. 7 C). In contrast, depletion of CD4+ T cells 
resulted in significantly (P < 0.05) increased and sustained 
viral replication in salivary glands compared with undepleted 
function (Volkmer et al., 1987). In the salivary glands, a site 
of viral persistence and transmission, control of virus is thought 
to require the combined activities of CD8+ and CD4+ T cells 
(Jonjic et al., 1989; Lucin et al., 1992). How interplays be-
tween different arms of the host immune response affect viral 
persistence in different organs is unknown. We were specifi-
cally interested in understanding whether the NK cell–mediated 
modulation of T cell responses could affect viral persistence 
in salivary glands. Persistent virus in salivary secretions is the 
major source of horizontal transmission for both murine and 
human CMV.
A  comparison  of  infectious  viral  titers  in  the  salivary 
glands of Ly49H– and Ly49H+ mice revealed significantly 
higher titers in Ly49H– mice at 10 d (P < 0.01), 18 d (P < 
0.0005), and 25 d (P < 0.0005) pi. Viral titers remained con-
stant at >104 PFU per organ in Ly49H+ mice 10–60 d after 
infection. In contrast, in Ly49H– mice, viral titers declined 
sharply by day 32, and no virus was detected in the salivary 
glands of these mice from day 40 onward (Fig. 6, A and B). 
These findings indicate that the capacity to limit viral persis-
tence differs in Ly49H– and Ly49H+ mice, and suggest that 
the NK cell regulated differences in T cell functions observed 
in these mice may contribute to the ability of the virus to 
persist in salivary glands.
Further independent evidence that NK cells regulate the 
responses required to limit viral persistence was obtained using 
viruses lacking the m157 viral glycoprotein. In Ly49H– mice, 
wild-type and m157 mutant viruses replicated to the same lev-
els in spleen, liver, lung, and salivary glands at all time points 
tested (unpublished data). In contrast, the persistent infection 
and sustained viral loads observed in salivary glands of Ly49H+ 
Figure 5.  More viral peptide–MHC complex avail-
able to T cells in Ly49H mice sustains ongoing  
T cell proliferation. Ly49H and Ly49H+ mice were in-
fected with 5 × 103 PFU of MCMV-K181-HA and APC 
populations enriched by density gradient and negative 
antibody enrichment on day 2, 4, and 6 pi. (A) The pheno-
type and frequency of the enriched populations is shown. 
Density plots (gated on live lymphocytes) depict the 
CD11c and Siglec H expression in Ly49H and Ly49H+ 
mice. (B) APCs were enriched from MCMV-K181-HA in-
fected Ly49H and Ly49H+ mice, as shown in A, at day 0, 
2, 4, and 6 pi, and incubated in vitro with CFSE-labeled 
Tg-HA CD8+ T cells for 5 d. Histograms show proliferation 
of CD8+ T cells (gated on live, TCR+, CD8+, and CD4). 
CD8+ T cells incubated with uninfected APCs are shown 
as gray-filled histograms. CD8+ T cells incubated with APC 
from 2, 4, and 6 d pi are shown as solid black lines. The 
frequencies of cells with diluting CFSE are shown. Data 
are representative of two independent experiments per-
formed in triplicate. All experiments were performed in 
BALB.B6-CT6 (Ly49H) and BALB.B6-CT8 (Ly49H+) mice.JEM VOL. 207, June 7, 2010 
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face of effective NK cell responses, the proportion and number 
of antigen-bearing APCs is reduced, and the extent of T cell 
activation is consequently limited. MCMV infection of DCs 
leads to decreased expression of MHC and co-stimulatory 
molecules, and functional impairment characterized by the in-
ability to stimulate alloreactive T cell responses (Andrews et al., 
2001). MCMV-induced DC impairment, however, is pre-
ceded by a phase of DC activation (Andrews et al., 2001), and 
indeed MCMV-infected DCs can efficiently prime autologous 
naive T cells (Mathys et al., 2003). Importantly, MCMV-
infected DCs are a major source of infectious viral progeny, 
and immature DCs are a principal target of MCMV infection 
mice (Fig. 7 C). Together, these results provide evidence that 
CD4+, but not CD8+ T cells, play a critical role in limiting 
viral persistence in salivary glands.
DISCUSSION
Using a model of persistent viral infection, we have defined 
a novel link between components of the innate and adaptive 
immune system, whereby NK cells limit the ongoing efficacy 
of virus-specific CD4+ and CD8+ T cell responses. We have 
shown that the effects of NK cells are mediated by controlling 
the frequency and duration of infection of DCs/APCs. In the 
Figure 6.  Viral persistence differs in Ly49H and Ly49H+ mice.  
(A) Titers of replicating virus in salivary glands of infected BALB/c and 
C57BL/6J mice are shown over a course of infection. Arithmetic means 
and standard errors are plotted. Data are combined results from at least 
three independent experiments each using three mice per time point.  
(B) Viral titers equivalent to those observed in C57BL/6 mice were obtained in 
Ly49H+ BALB/c congenic mice. Arithmetic means and standard errors are 
plotted. Each data point represents six mice (three BALB.B6-Cmv1r and 
three BALB.B6-CT8). Data from BALB.B6-Cmv1r and BALB.B6-CT8 were 
combined because both strains are identical in respect to MCMV growth 
characteristics in vivo. Day 32 and day 40, P = 0.0022 when comparing 
Ly49H with Ly49H+ mice. (C) Viral persistence in the salivary glands of 
Ly49H+ mice infected with a mutant virus lacking m157 is reduced, and is 
equivalent to that observed in Ly49H mice. Ly49H+ C57BL/6 mice were 
infected with wild-type virus (MCMV-m157WT) or a virus with a nonfunc-
tional m157 glycoprotein (MCMV-m157MUT). A revertant virus (MCMV-
m157REV), generated by inserting a functional m157 glycoprotein in the 
MCMV-m157MUT, was also used. Organs were collected at days 32, 40, and 
50 pi. Titers of replicating virus in the salivary glands are shown as arith-
metic means and standard errors. n = 7. Day 40, P = 0.0313 when com-
paring MCMV-m157MUT with MCMV-m157REV.
Figure 7.  Viral persistence differs in Ly49H and Ly49H+ mice 
because of differences in CD4+ T cell responses. (A) Absolute numbers 
of CD8+IE1+ T cells from three mice and representative of four indepen-
dent experiments and (B) absolute numbers of CD4+IFN-+ T cells from 
data pooled from five experiments (n = 15) at various times pi in the sali-
vary glands of Ly49H and Ly49H+ mice infected with MCMV (5 × 103 PFU). 
Absolute numbers are shown as arithmetic means and standard error.  
(C) Viral titers in the salivary glands of Ly49H mice depleted of either 
CD4+ or CD8+ T cells after infection with 104 PFU MCMV are shown. 
Titers in infected, undepleted Ly49H mice are shown for comparison. 
Arithmetic means and standard errors were plotted from one representa-
tive experiment with three mice per group and are representative results 
obtained in four independent experiments. *, P < 0.05. BALB/c (Ly49H) 
and BALB.B6-CT8 (Ly49H+) mice were used in the experiments described 
in A, except one where BALB.B6-CT6 (Ly49H) mice were used instead of 
BALB/c (Ly49H) mice. The experiments described in B were performed 
three times in BALB/c (Ly49H) and twice in BALB.B6-CT6 (Ly49H) in 
comparison with BALB.B6-CT8 (Ly49H+) mice. BALB/c (Ly49H) mice were 
used for all experiments described in C.1340 Innate immunity and persistent infection | Andrews et al.
these interplays therapeutically. Two previous studies have 
demonstrated that NK cells are able to temporally accelerate 
(Robbins et al., 2007) or enhance (Krebs et al., 2009) adap-
tive immune responses, particularly the CD8+ T cell response. 
Although these results appear to be at odds with those of our 
studies, we believe they point to a complex set of interplays 
between the innate and adaptive immune systems that are slowly 
being unraveled. Our current data demonstrate that caution 
needs to be taken when considering approaches that activate 
NK cells therapeutically, because, in some circumstances, an 
over effective NK cell response may be detrimental to the 
quality of ongoing T cell responses.
In the context of our current findings, it is worth noting 
a study that analyzed the impact of polymorphisms in the 
inhibitory  NK  cell  receptor  KIR3DL1  on  HIV-1  disease 
progression in a large cohort of >1,500 HIV-1–infected indi-
viduals (Martin et al., 2007). The data showed that high ex-
pression of the inhibitory NK cell receptor KIR3DL1 and its 
HLA ligand (Bw4-801) confers protection from AIDS progres-
sion. This unexpected result has been explained “by a model 
in which greater dependency on the expression of specific 
KIR3DL1 + Bw4 receptor–ligand pairs for NK cell inhi-
bition in the resting state (where KIR3DL1*h > KIR3DL1*l) 
results in more pronounced NK cell responses when that in-
hibition is abrogated in the face of infection” (Martin et al., 
2007). In view of our current results, an alternative explana-
tion may be that inhibition of NK cell activities allows 
HIV-infected DCs to be maintained longer, resulting in bet-
ter ongoing HIV-specific T cell responses and, ultimately, 
protection from AIDS progression.
Notably, our data have shown that impairment of antivi-
ral T cell responses contributes significantly to viral persis-
tence, and have clearly demonstrated that ongoing CD4+ 
T cell responses, independently of CD8+ T cell responses, are 
critical for this effect. This was somewhat unexpected given 
that both CD4+ and CD8+ T cells are present in greater 
numbers in the salivary glands of mice displaying reduced 
viral persistence. Recent studies have demonstrated that the 
efficacy of antiviral CD8+ T cells is limited by their capacity 
to maintain contact with virally infected targets long enough 
to result in their elimination (unpublished data). Most MCMV-
infected targets down-regulate MHC-I, and many of the 
pathogens that, like CMV, cause a persistent infection have 
evolved elaborate strategies to avoid immune recognition. 
We postulate that in chronic infections control of persistent 
virus will require activities mediated by CD4+ T cells. In 
HIV infection, although an impairment in the function of 
CD8+ T cells has been postulated to be responsible for the 
inability to control persistent infection (Appay et al., 2000; 
Champagne et al., 2001), additional evidence suggests that 
successful control of viral persistence requires efficient CD4+ 
T cell responses (Rosenberg et al., 1997; Pitcher et al., 1999; 
Boaz et al., 2002; Harari et al., 2004; D’Souza et al., 2007; 
Kaufmann et al., 2007). Similarly, suboptimal CD4+ T cell 
responses are associated with persistent HCV infection and 
chronic disease (for review see Semmo and Klenerman, 2007). 
(Andrews et al., 2001). Based on these findings and our current 
results, we propose the following model. Immediately after in-
fection, MCMV-infected DCs are activated and prime naive 
T cells in both Ly49H– and Ly49H+ mice. In Ly49H– mice, 
where the NK cell response is suboptimal, MCMV-infected 
DCs are not eliminated. Despite the fact that infected DCs be-
come functionally impaired some time after infection, they re-
main a major source of progeny virus which can in turn infect 
immature DCs, including those repopulating the spleen, and 
thus maintain a pool of effective APCs over a long period of 
time. In contrast, the NK cell–mediated elimination of infected 
DCs in Ly49H+ mice limits the ongoing priming of antiviral 
T cells by removing the cells that are the source of infectious 
virus soon after infection. To our knowledge, this is the first 
physiological characterization of the mechanism whereby NK 
cells affect the ongoing effectiveness of T cell responses by limit-
ing exposure to professional APCs. Importantly, we have also 
shown that the mechanisms by which NK cells limit the expo-
sure of naive T cells to infected APCs is perforin-mediated 
elimination of infected cells.
Our observations show that antiviral CTL responses are 
modulated by NK cells, and specifically by Ly49H+ NK cells. 
Furthermore, we found that the interaction of the m157 viral 
glycoprotein with the Ly49H NK cell activating receptor fa-
vors viral persistence in salivary glands. Previous studies have 
analyzed the role of the m157 viral protein during acute viral 
infection. Binding of m157 to host Ly49H NK cell receptors 
delivers activating signals to NK cells (Arase et al., 2002; Smith 
et al., 2002). The involvement of a viral protein in activating 
antiviral responses was partly reconciled by the finding that 
m157 can rapidly mutate in response to repeated passage 
through Ly49H+ mice, and consequently lose the capacity to 
activate NK cells (Voigt et al., 2003). These studies provided 
a clear example of how MCMV evolves in response to strong 
repeated selection pressure, such as the one imposed by NK 
cells during acute infection. Such pressure is likely to compro-
mise the ability of the virus to replicate, and hence viruses 
with mutated m157 are selected as they have a growth advan-
tage over parent virus. We were prompted to analyze the 
long-term role of m157 because it seemed peculiar that a viral 
protein would activate antiviral responses without any ulti-
mate benefit to the virus. The effects of m157 we present in 
the current study relate to transmission and evolutionary sur-
vival and the relevant mechanisms represent manipulation of 
host immune responses, rather than blocking, as afforded by 
mutating the m157 sequence. Developing means to specifi-
cally favor viral transmission and evolutionary survival as 
opposed to ensuring early viral replication are very different 
challenges, but both are dealt with by MCMV very efficiently. 
The results presented here resolve the apparent incongruity as 
to the role of a viral protein that apparently favors early anti-
viral immunity mediated by NK cells, and present exciting 
evidence of a new strategy of viral immune evasion.
Several studies have highlighted the role of innate immu-
nity in promoting the adaptive response (for review see 
Degli-Esposti and Smyth, 2005) and the potential for exploiting JEM VOL. 207, June 7, 2010 
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mutant virus (K181-m157-MUT) was also generated using a K181 BAC 
pARK25 backbone (K181-m157-WT). K181-m157-MUT carries the pre-
viously described C2 mutation which results in a premature stop codon in 
the m157 sequence and a lack of m157 expression (Voigt et al., 2003). A re-
vertant virus (K181-m157-REV) was generated by replacing the mutated 
m157 sequence in the K181-m157-MUT virus with a wild-type full-length 
m157 sequence.
In vivo CTL assay. Virus-specific, CTL-mediated cytotoxicity was assessed 
by measuring the elimination of targets pulsed with the IE1 viral peptide 
YPHFMPTNL. The in vivo CTL assay quantifies CTL activity by measuring 
the loss of specific peptide-pulsed targets in comparison to targets that have not 
been pulsed with peptide. Here, target cell lysis was measured using a modifi-
cation of a previously described assay (Barber, 2001). IE1 peptide–pulsed 
(0.02 µg/ml) splenocyte targets were labeled with a low concentration (final, 
0.025 µM) of CFSE (Invitrogen), whereas control targets, not pulsed with pep-
tide, were labeled with a high concentration (final, 0.25 µM) of CFSE. Labeled 
cells were washed to remove free CFSE and differential labeling confirmed 
by flow cytometry. CFSE-low IE1–pulsed targets and CFSE-high–unpulsed 
control targets were resuspended in PBS, mixed in equal proportions, and a total 
of 4 × 107 cells per mouse transferred intravenously into syngeneic mice that 
had been infected with MCMV for various periods of time. Mice were sacri-
ficed 18 h later, and single-cell suspensions from spleen, lung, and cervical and 
parotid lymph nodes analyzed by flow cytometry. Transferred cells serve as 
targets for peptide-specific CTL. The frequency of unpulsed targets serves as 
an internal control for trafficking, recovery, and nonspecific cell loss. The loss 
of specific peptide-pulsed targets is a measure of CTL activity against targets 
pulsed with the IE1 viral peptide. Specific lysis was determined using the fol-
lowing formula: percentage specific lysis of CFSE-labeled target cells in each 
mouse is calculated as follows: (1  [r uninfected control mouse/r infected 
test mouse]) × 100 where r = (frequency of unpulsed targets/frequency 
of peptide-pulsed targets). The assay is a very sensitive and specific method to 
measure MHC class I–restricted, CD8-dependent lysis in vivo.
NK cell depletion. NK cells were depleted using the NK1.1-specific mAb 
PK136 at days 2, 0, and 2 relative to MCMV infection, as previously de-
scribed (Scalzo et al., 1992). Depletion was confirmed using 51Cr-labeled 
YAC cells as targets in a standard 4-h NK cell lysis assay.
DC enrichment. Spleens were cut into small fragments and incubated in 
IMDM, 2% FCS medium containing collagenase (1 mg/ml, type IV; Invit-
rogen) for 25 min at room temperature with continuous agitation. EDTA 
was added at a concentration of 0.01 M and incubation continued for 5 min. 
Undigested material was removed by filtering through a stainless steel sieve 
and cells pelleted by centrifugation. Cells were then resuspended in PBS and 
overlaid with isoosmotic OptiPrep (Nyegaard Diagnostics) solutions for DC 
purification, as described by the manufacturer. The low-density fraction was 
obtained by centrifugation at 600 g for 15 min. Cells in the low-density frac-
tion, accounting for 1% of the starting cell population, were washed and 
used for further analysis.
Flow cytometry. Single-cell suspensions were preincubated on ice for 
30 min with EDTA-SS-FCS containing 20% normal goat serum. To detect 
IE1-specific T cells, APC-conjugated TCR (H57-597; BioLegend) was 
used together with APC-Cy7–conjugated CD8 (53–6.7; BioLegend) and 
PE-conjugated  H-2Ld-168-YPHFMPTNL-176  MCMV  IE1  tetramer 
(ImmunoID Tetramers). To assess the activation status of CD8 T cells, APC-
Cy7–conjugated  CD8  (53–6.7;  BioLegend)  and  FITC-conjugated  TCR 
(H57-597; BioLegend) were used together with PE-Cy7–conjugated CD69 
(H1-2F3;  BD).  To  detect  MCMV-infected  DCs,  PE-conjugated  CD11c 
(HL-3), PE-Cy7–conjugated CD11b (M1/70), APC-Cy7–conjugated CD8 
(53–6-7),  and  APC-conjugated  I-A/I-E  (M5/114-15-2)  from  BioLegend 
were used together with FDG (Invitrogen). 7-amino-actinomycin D was in-
corporated into the final wash at 2 µg/ml to exclude dead cells from the analy-
sis. The fluorescence-labeled preparations were analyzed on a FACSCanto (BD). 
Thus, as originally proposed (Matloubian et al., 1994), accu-
mulating evidence suggests that CD4+ T cell responses are 
a critical component of effective antiviral responses and are 
particularly important to limit persistent infection. The mecha-
nisms that account for the failure of these responses in chronic 
infection however have, until now, remained unclear. Our 
results define the impact of NK cells and APCs in shaping the 
quality of CD4 T cell responses in MCMV, and their ability 
to limit viral persistence in salivary glands, the main site of 
viral transmission. These findings provide new insights in the 
management of persistent viral pathogens, but also demon-
strate the general utility of exploiting the basic biology of 
viral infection to better understand how the immune system 
works and how to interfere with some of its specific func-
tions. This type of analysis defines the key molecular events 
and checkpoints that need to be targeted to alter the outcome 
of immune responses. Our current data provide grounds to 
reassess the interplay between innate and adaptive immune 
responses, not only in the context of infectious diseases, but 
also tumor immunology and transplantation.
MATERIALS AND METHODS
Mice. Inbred C57BL/6J (H-2b, I-Ab, NK1.1+ Ly49H+) and BALB/c (H-2d, 
I-Ad, NK1.1– Ly49H–) mice of 8 wk of age were obtained from the Animal 
Resources Centre (Perth, Western Australia). The Ly49H+ congenic strains 
BALB.B6-CT8  (H-2d,  I-Ad,  NK1.1+,  and  Ly49H+),  BALB.B6-Cmv1r 
(H-2d, I-Ad, NK1.1+, and Ly49H+), BALB.B6-CT13 (H-2d, I-Ad, NK1.1¯, 
and Ly49H+) and BALB.B6-Cmv1r.pfp/, and the congenic Ly49H– strain 
BALB.B6-CT6 (H-2d, I-Ad, NK1.1+, and Ly49H¯; Scalzo et al., 1999) were 
bred in the Animal Services Facility of the University of Western Australia. 
All mice were maintained in this facility during the course of infection. All 
animal experimentation was performed with the approval of the Animal 
Ethics and Experimentation Committee of the University of Western Aus-
tralia, according to the guidelines of the National Health and Medical Re-
search Council.
MCMV infection. Mice were infected by intraperitoneal administration of 
5 × 103 or 102 PFU of salivary gland propagated MCMV diluted in PBS-
0.05% FCS. The viruses used were as follows: MCMV-K181-Perth (referred 
to  as  MCMV);  MCMV-K181-Perth-LacZ,  which  is  a  virus  genetically 
modified to encode the LacZ gene in the intron of the m129-m131 open 
reading frame; or MCMV-K181-Perth-HA, which is a virus genetically mod-
ified to carry the CD8 CL4/H2Kd-restricted HA (512–520) IYSTVASSL 
epitope from mouse influenza at the end of the MCMV ie1 gene. Control 
mice received PBS/0.05% FCS.
m157 mutant viruses. Three MCMV mutants (C2, C6, and E4) derived 
from the wild-type MCMV-K181 contain mutations in the m157 ORF; 
these viruses are referred to as MCMV-m157mut. The derivation of the 
C2 and C6 MCMV-m157mut viruses is described in our previously published 
study (Voigt et al., 2003). In addition, we purified additional independent 
m157 mutants, including the E4 used here, from the salivary glands of 
C57BL/6 mice sequentially infected two times with virus, as described 
(Voigt et al., 2003). The E4 MCMV-m157 mutant carries a 1-bp deletion at 
nucleotide position 216,833 (relative to the nucleotide assignment in the 
prototypic Smith MCMV strain sequence) resulting in a frame shift and pre-
mature stop. The MCMV-m157mut E4 clone was confirmed incapable of 
activating Ly49H, as previously described (Voigt et al., 2003). A wild-type 
MCMV clone was purified concurrently, and designated MCMV-m157wt. 
The MCMV-m157wt and MCMV-m157mut E4 viruses were confirmed to 
be clonal by serial dilution, sequencing, and functional analyses. An m157 1342 Innate immunity and persistent infection | Andrews et al.
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DCs were isolated from BALB.B6-CT6 and BALB.B6-CT8 mice. In brief, 0, 
2, 4, and 6 d after infection, 3 spleens were harvested and pooled from mice 
infected with 5 × 103 PFU MCMV-K181-Perth-HA. Organs were pro-
cessed and cells were purified over a Nycodenz gradient. DCs were isolated 
by negative selection using anti-CD3 (KT3-1.1), anti-Thy1 (T24/31.7), 
anti-Ly6G (1A8), anti-CD19 (ID3), and anti-erythrocyte (TER119). After 
co-culture, T cell proliferation was measured after staining with CD4, CD8, 
TCR, and PI, and assessing CFSE dilution.
Measuring virus in salivary glands after depletion of CD4+ or CD8+ 
T cells. Mice were infected by intraperitoneal administration of 104 PFU 
MCMV. CD4+ T cells were depleted using 500 µg of the CD4-specific mAb 
GK1.5 per delivery. CD8+ T cells were depleted using 250 µg of the CD8 
specific mAb 53.5.8 per delivery. Mice were (a) depleted on days 9, 11, 16, 
and 20 pi and salivary glands were harvested on day 25; (b) depleted on days 
16, 18, 23, and 27 pi and salivary glands harvested on day 32; or (c) depleted   
on days 24, 26, 31, and 35 pi and salivary glands harvested on day 40. Depletion   
was confirmed by flow cytometry. Salivary glands were harvested and homog-
enized, and virus titers were determined (Andrews et al., 2003).
Statistical analysis. Two-tailed Mann-Whitney tests were performed 
using InStat (GraphPad Software). All data are shown as mean ± SE.
Online supplemental material. Table S1 summarizes the CTL response in 
Ly49H- and Ly49H+ mice after MCMV infection. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20091193/DC1.
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